Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH
Status:
Not yet recruiting
Trial end date:
2024-06-10
Target enrollment:
Participant gender:
Summary
This is a Phase 2, Double-Blind, Randomized, Multicenter, Placebo-controlled Study to
Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults with Nonalcoholic
Steatohepatitis (NASH).